Blood proteins – PharmaLive

FDA Approves Prophylactic Treatment with VONVENDI for Adult Patients Living with Severe Type 3 von Willebrand Disease

Bleeding Disorders, Blood proteins, Inherited Disorders, Takeda, Therapeutics, von Willebrand Disease (VWD), Von Willebrand Factor (VWF)

The U.S. Food and Drug Administration approved Takeda Pharmaceutical Company Limited’s Vonvendi [von Willebrand factor (Recombinant)] for routine prophylaxis to reduce the frequency of bleeding episodes in patients with severe Type 3 von Willebrand disease (VWD) receiving on-demand therapy.

January 31, 2022/by Business Wire

A Blood Test That Can ID Alzheimer’s Risk Up To 16 Years Before Symptoms

Alzheimer's, Alzheimer’s disease, Biomarkers, Blood, Blood proteins, Collaborations, Neurodegenerative Disorders, Neurofilament light chain (NfL) protein, PhRMA, Proteins, R&D, Researchers, Scientists

Scientists at DZNE, HIH, and the University Hospital Tuebingen identified a protein in blood that can precisely track Alzheimer’s disease progression before the first symptoms appear.

January 22, 2019/by BioSpace